Chicago Partners Investment Group LLC
Position in ELAN — Elanco Animal Health Inc
CIK 1563525
CHICAGO, IL
Position in ELAN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$379,830
+$47,515 QoQ
Shares Held
15,434
+11.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#310
of 519 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Chicago Partners Investment Group LLC holds $3,695,869 across 13 Drug Manufacturers - Specialty & Generic names. ELAN ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
8,472 | $1,427,870 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,179 | $638,817 | |
| 3 | ELAN |
Elanco Animal Health Inc
This page
|
15,434 | $379,830 | |
| 4 | ZTS |
Zoetis Inc.
|
5,190 | $372,953 | |
| 5 | VTRS |
Viatris Inc
|
15,036 | $238,771 | |
| 6 | EOLS |
Evolus, Inc.
|
22,248 | $154,401 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
14,488 | $144,880 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
11,425 | $90,486 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $379,830 | 15,434 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $332,315 | 13,887 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $313,561 | 13,856 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $293,882 | 14,592 | Shares | Sole | 2025-10-30 | |
| No filing history on record for this holder in this stock. | ||||||